p.93 抽出テキスト

761. Dolgner SJ, Arya B, Kronman MP, Chan T. Effect of congenital heart disease status on trends in pediatric infective endocarditis hospitalizations in the United States between 2000 and 2012. Pediatr Cardiol 2019;40:319–329. https://doi.org/10.1007/s00246-018- 2020-7 762. Jortveit J, Klcovansky J, Eskedal L, Birkeland S, Dohlen G, Holmstrom H. Endocarditis in children and adolescents with congenital heart defects: a Norwegian nationwide register-based cohort study. Arch Dis Child 2018;103:670–674. https://doi.org/10. 1136/archdischild-2017-313917 763. Cahill TJ, Jewell PD, Denne L, Franklin RC, Frigiola A, Orchard E, et al. Contemporary epidemiology of infective endocarditis in patients with congenital heart disease: a UK prospective study. Am Heart J 2019;215:70–77. https://doi.org/10.1016/j.ahj.2019.05. 014 764. Tutarel O, Alonso-Gonzalez R, Montanaro C, Schiff R, Uribarri A, Kempny A, et al. Infective endocarditis in adults with congenital heart disease remains a lethal disease. Heart 2018;104:161–165. https://doi.org/10.1136/heartjnl-2017-311650 765. Bauer UMM, Helm PC, Diller GP, Asfour B, Schlensak C, Schmitt K, et al. Are adults with congenital heart disease informed about their risk for infective endocarditis and treated in accordance to current guidelines? Int J Cardiol 2017;245:105–108. https://doi.org/10.1016/j.ijcard.2017.07.040 766. Watkins DA, Beaton AZ, Carapetis JR, Karthikeyan G, Mayosi BM, Wyber R, et al. Rheumatic heart disease worldwide: JACC Scientific Expert Panel. J Am Coll Cardiol 2018;72:1397–1416. https://doi.org/10.1016/j.jacc.2018.06.063 767. Bajracharya S, Khanal B, Siwakoti S, Singh RR, Sharma SK. Microbiological and clinicoepidemiological profile of a series of patients with infective endocarditis at a center in Eastern Nepal. Can J Infect Dis Med Microbiol 2021;2021:9980465. https://doi.org/10. 1155/2021/9980465 768. Karthikeyan G, Zuhlke L, Engel M, Rangarajan S, Yusuf S, Teo K, et al. Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study. Am Heart J 2012;163:535–540.e1. https://doi.org/10.1016/j.ahj.2012.01.003 769. Zuhlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J 2015;36:1115–1122a. https://doi.org/10.1093/eurheartj/ehu449 770. Zuhlke L, Karthikeyan G, Engel ME, Rangarajan S, Mackie P, Cupido-Katya Mauff B, et al. Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low- and middle-income countries: two-year follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY study). Circulation 2016;134:1456–1466. https://doi.org/10.1161/CIRCULATIONAHA.116.024769 771. Rohn V, Laca B, Horn M, Vlk L, Antonova P, Mosna F. Surgery in drug use-associated infective endocarditis: long-term survival is negatively affected by recurrence. Interact Cardiovasc Thorac Surg 2020;30:528–534. https://doi.org/10.1093/icvts/ivz302 772. Kumar RK, Antunes MJ, Beaton A, Mirabel M, Nkomo VT, Okello E, et al. Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American Heart Association. Circulation 2020;142:e337–e357. https://doi.org/10.1161/CIR.0000000000000921 773. Coates MM, Sliwa K, Watkins DA, Zuhlke L, Perel P, Berteletti F, et al. An investment case for the prevention and management of rheumatic heart disease in the African Union 2021–30: a modelling study. Lancet Glob Health 2021;9:e957–e966. https:// doi.org/10.1016/S2214-109X(21)00199-6 774. Zilla P, Yacoub M, Zuhlke L, Beyersdorf F, Sliwa K, Khubulava G, et al. Global unmet needs in cardiac surgery. Glob Heart 2018;13:293–303. https://doi.org/10.1016/j. gheart.2018.08.002 775. Mirabel M, Andre R, Barsoum P, Colboc H, Lacassin F, Noel B, et al. Ethnic disparities in the incidence of infective endocarditis in the Pacific. Int J Cardiol 2015;186:43–44. https://doi.org/10.1016/j.ijcard.2015.03.243 776. Mirabel M, Andre R, Barsoum Mikhail P, Colboc H, Lacassin F, Noel B, et al. Infective endocarditis in the Pacific: clinical characteristics, treatment and long-term outcomes. Open Heart 2015;2:e000183. https://doi.org/10.1136/openhrt-2014-000183 777. Kingue S, Ba SA, Balde D, Diarra MB, Anzouan-Kacou JB, Anisubia B, et al. The valvafric study: a registry of rheumatic heart disease in Western and Central Africa. Arch Cardiovasc Dis 2016;109:321–329. https://doi.org/10.1016/j.acvd.2015.12.004 778. Subbaraju P, Rai S, Morakhia J, Midha G, Kamath A, Saravu K. Clinical – microbiological characterization and risk factors of mortality in infective endocarditis from a tertiary care academic hospital in southern India. Indian Heart J 2018;70:259–265. https:// doi.org/10.1016/j.ihj.2017.08.007 779. Rwebembera J, Manyilirah W, Zhu ZW, Nabbaale J, Namuyonga J, Ssinabulya I, et al. Prevalence and characteristics of primary left-sided valve disease in a cohort of 15,000 patients undergoing echocardiography studies in a tertiary hospital in Uganda. BMC Cardiovasc Disord 2018;18:82. https://doi.org/10.1186/s12872-018- 0813-5 780. Pecoraro AJ, Doubell AF. Infective endocarditis in South Africa. Cardiovasc Diagn Ther 2020;10:252–261. https://doi.org/10.21037/cdt.2019.06.03 781. Hajsadeghi S, Hassanzadeh M, Hajahmadi M, Kadivar M. Concurrent diagnosis of infective endocarditis and acute rheumatic fever: a case report. J Cardiol Cases 2018;17: 147–150. https://doi.org/10.1016/j.jccase.2017.12.011 782. Gouriet F, Chaudet H, Gautret P, Pellegrin L, de Santi VP, Savini H, et al. Endocarditis in the Mediterranean Basin. New Microbes New Infect 2018;26:S43–S51. https://doi.org/ 10.1016/j.nmni.2018.05.004 783. Dhar M, Kaeley N, Bhatt N, Ahmad S. Profile of newly diagnosed adult patients with rheumatic heart disease in sub-Himalayan region – a 5-year analysis. J Family Med Prim Care 2019;8:2933–2936. https://doi.org/10.4103/jfmpc.jfmpc_363_19 784. Blanchard V, Pagis B, Richaud R, Moronval F, Lutinier R, Gallais K, et al. Infective endocarditis in French Polynesia: epidemiology, treatments and outcomes. Arch Cardiovasc Dis 2020;113:252–262. https://doi.org/10.1016/j.acvd.2019.12.007 785. Montano TCP, Wanderley MIA, Sampaio RO, Alves CGB, Neves ILI, Lopes MA, et al. Demographic, cardiological, microbiologic, and dental profiles of Brazilian patients who developed oral bacteria-related endocarditis. Oral Surg Oral Med Oral Pathol Oral Radiol 2021;132:418–425. https://doi.org/10.1016/j.oooo.2021.07.007 786. Jomaa W, Ben Ali I, Abid D, Hajri Ernez S, Abid L, Triki F, et al. Clinical features and prognosis of infective endocarditis in children: insights from a Tunisian multicentre registry. Arch Cardiovasc Dis 2017;110:676–681. https://doi.org/10.1016/j.acvd.2016. 12.018 787. Mahony M, Lean D, Pham L, Horvath R, Suna J, Ward C, et al. Infective endocarditis in children in Queensland, Australia: epidemiology, clinical features and outcome. Pediatr Infect Dis J 2021;40:617–622. https://doi.org/10.1097/INF.0000000000003110 788. Willoughby ML, Basera W, Perkins SR, Comitis GAM, Fourie B, Lawrenson JB, et al. Infective endocarditis in infants and children in the Western Cape, South Africa: a retrospective analysis. Cardiol Young 2019;29:1282–1286. https://doi.org/10.1017/ S1047951119002154 789. Nigussie B, Tadele H. Heart failure in Ethiopian children: mirroring the unmet cardiac services. Ethiop J Health Sci 2019;29:811–818. https://doi.org/10.4314/ejhs.v29i1.2 790. Moreira JL, Barletta P, Baucia JA. Morbidity and mortality in patients undergoing mitral valve replacement at a cardiovascular surgery referral service: a retrospective analysis. Braz J Cardiovasc Surg 2021;36:183–191. https://doi.org/10.21470/1678-9741-2019- 0440 791. Mocumbi AO, Jamal KK, Mbakwem A, Shung-King M, Sliwa K. The Pan-African Society of Cardiology position paper on reproductive healthcare for women with rheumatic heart disease. Cardiovasc J Afr 2018;29:394–403. https://doi.org/10.5830/CVJA-2018- 044 792. Roos-Hesselink J, Baris L, Johnson M, De Backer J, Otto C, Marelli A, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC registry of pregnancy and cardiac disease (ROPAC). Eur Heart J 2019;40: 3848–3855. https://doi.org/10.1093/eurheartj/ehz136 793. De Villiers MC, Viljoen CA, Manning K, Van der Westhuizen C, Seedat A, Rath M, et al. The changing landscape of infective endocarditis in South Africa. S Afr Med J 2019;109: 592–596. https://doi.org/10.7196/SAMJ.2019.v109i8.13888 794. Sadeghpour A, Maleki M, Movassaghi M, Rezvani L, Noohi F, Boudagh S, et al. Iranian Registry of Infective Endocarditis (IRIE): time to relook at the guideline, regarding to regional differences. Int J Cardiol Heart Vasc 2020;26:100433. https://doi.org/10.1016/ j.ijcha.2019.100433 795. Wu Z, Chen Y, Xiao T, Niu T, Shi Q, Xiao Y. Epidemiology and risk factors of infective endocarditis in a tertiary hospital in China from 2007 to 2016. BMC Infect Dis 2020;20: 428. https://doi.org/10.1186/s12879-020-05153-w 796. Xu H, Cai S, Dai H. Characteristics of infective endocarditis in a tertiary hospital in east China. PLoS One 2016;11:e0166764. https://doi.org/10.1371/journal.pone.0166764 797. Connolly C, O’Donoghue K, Doran H, McCarthy FP. Infective endocarditis in pregnancy: case report and review of the literature. Obstet Med 2015;8:102–104. https:// doi.org/10.1177/1753495X15572857 798. Yuan SM. Infective endocarditis during pregnancy. J Coll Physicians Surg Pak 2015;25: 134–139. 799. Escola-Verge L, Rello P, Declerck C, Dubee V, Rouleau F, Duval X, et al. Infective endocarditis in pregnant women without intravenous drug use: a multicentre retrospective case series. J Antimicrob Chemother 2022;77:2701–2705. https://doi.org/10.1093/jac/ dkac258 800. Dagher MM, Eichenberger EM, Addae-Konadu KL, Dotters-Katz SK, Kohler CL, Fowler VG, et al. Maternal and fetal outcomes associated with infective endocarditis in pregnancy. Clin Infect Dis 2021;73:1571–1579. https://doi.org/10.1093/cid/ciab533 801. Morelli MK, Veve MP, Shorman MA. Maternal bacteremia caused by Staphylococcus aureus with a focus on infective endocarditis. Open Forum Infect Dis 2020;7:ofaa239. https://doi.org/10.1093/ofid/ofaa239 802. English N, Weston P. Multivalvular infective endocarditis in pregnancy presenting with septic pulmonary emboli. BMJ Case Rep 2015;2015:bcr2014209131. https://doi.org/ 10.1136/bcr-2014-209131 803. Khanna R, Chandra D, Yadav S, Sahu A, Singh N, Kumar S, et al. Maternal and fetal outcomes in pregnant females with rheumatic heart disease. Indian Heart J 2021;73: 185–189. https://doi.org/10.1016/j.ihj.2021.01.012 804. Adesomo A, Gonzalez-Brown V, Rood KM. Infective endocarditis as a complication of intravenous drug use in pregnancy: a retrospective case series and literature review. AJP Rep 2020;10:e288–e293. https://doi.org/10.1055/s-0040-1716732 Downloaded from academic.oup.com/eurheartj/article/44/39/3948/7243107 by guest on 07 October 2026